ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.
Saved in:
| Title: | ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. |
|---|---|
| Authors: | Li D; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., March ME; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Gutierrez-Uzquiza A; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Biochemistry and Molecular Biology II, School of Pharmacy, Complutense University, Madrid, Spain., Kao C; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Seiler C; Zebrafish Core Facility, The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA., Pinto E; Center for Lymphatic Imaging and Interventions, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Matsuoka LS; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Battig MR; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Bhoj EJ; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Wenger TL; Division of Craniofacial Medicine, Seattle Children's Hospital, Seattle, WA, USA., Tian L; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Robinson N; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Wang T; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Liu Y; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Weinstein BM; Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Swift M; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA., Jung HM; Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Kaminski CN; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Chiavacci R; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Perkins JA; Division of Otolaryngology-Head and Neck Surgery, Seattle Children's Hospital, Seattle, WA, USA., Levine MA; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sleiman PMA; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hicks PJ; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Strausbaugh JT; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Belasco JB; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Dori Y; Center for Lymphatic Imaging and Interventions, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hakonarson H; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. hakonarson@email.chop.edu.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. hakonarson@email.chop.edu.; Divisions of Human Genetics and Pulmonary Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. hakonarson@email.chop.edu. |
| Source: | Nature medicine [Nat Med] 2019 Jul; Vol. 25 (7), pp. 1116-1122. Date of Electronic Publication: 2019 Jul 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
